RELN gene loss function in several tumors, including pancreatic [79], gastric [80], and BC [81], A high risk of recurrence of hepatocellular carcinoma is related to decreased expression of RELN, which was also associated with increased migratory ability, shorter survival, and a poor prognosis [82]. This evidence concerns the gene RELN and breast cancer.